Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases

Details for Australian Patent Application No. 2004311421 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.; Faleck, Herbert; Schafer, Peter H.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004311421

PCT Pub. Number WO2005/065372

Priority 60/533,864 30.12.03 US

Filing date 27 December 2004

Wipo publication date 21 July 2005

International Classifications

A61K 31/454 (2006.01)

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/065372 Priority application(s): WO2005/065372

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004311425-Intrusion detection system

2004311420-Immunomodulatory compounds for the treatment of central nervous system disorders